1. A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomas. Issue 10 (3rd October 2017) Authors: Sborov, Douglas W.; Canella, Alessandro; Hade, Erinn M.; Mo, Xiaokui; Khountham, Soun; Wang, Jiang; Ni, Wenjun; Poi, Ming; Coss, Christopher; Liu, Zhongfa; Phelps, Mitch A.; Mortazavi, Amir; Andritsos, Leslie; Baiocchi, Robert A.; Christian, Beth A.; Benson, Don M.; Flynn, Joseph; Porcu, Pierluig... Journal: Leukemia & lymphoma Issue: Volume 58:Issue 10(2017) Page Start: 2310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. G-CSF improves safety when you start the day after autologous transplant in multiple myeloma. Issue 12 (2nd December 2017) Authors: Sborov, Douglas W.; Cho, Yu Kyoung; Cottini, Francesca; Hade, Erinn M.; Lamprecht, Misty; Tackett, Karen; Sharma, Nidhi; Williams, Nita; Li, Junan; Devine, Steven; Poi, Ming; Phelps, Mitch A.; Hofmeister, Craig C. Journal: Leukemia & lymphoma Issue: Volume 58:Issue 12(2017) Page Start: 2947 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Metastatic melanoma patients' sensitivity to ipilimumab cannot be predicted by tumor characteristics. Issue 9 (October 2017) Authors: Rossfeld, Kara; Hade, Erinn M.; Gangi, Alexandra; Perez, Matthew; Kinsey, Emily N.; Grabska, Joanna; Ederle, Ashley; Zager, Jonathan; Salama, April K.; Olencki, Thomas E; Beasley, Georgia M Journal: International journal of surgery Issue: Volume 2:Issue 9(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗